Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics

Area of Science:

• Proteomics
• Biomarker Discovery
• Analytical Chemistry

Background:

• Biomarker discovery requires efficient separation of low-abundance proteins from complex biological samples like plasma.
• Current methods face challenges in achieving the necessary sensitivity and throughput for comprehensive proteome analysis.
• Multi-dimensional fractionation systems (MDFS) offer a promising approach to overcome these limitations.

Purpose of the Study:

• To review recent advancements in Multi-dimensional Fractionation Systems (MDFS) for plasma proteome analysis.
• To evaluate MDFS performance based on the '4RS criterion' (resolution, reproducibility, recovery, robustness) and '4S criterion' (simplicity, speed, selectivity, sensitivity).
• To discuss the future perspectives of MDFS in plasma-derived biomarker discovery.

Main Methods:

• Literature review of recent advances in MDFS technology.
• Evaluation of MDFS performance metrics including resolution, reproducibility, recovery, robustness, simplicity, speed, selectivity, and sensitivity.
• Analysis of sample processing, yield, and throughput considerations in MDFS for plasma proteomics.

Main Results:

• MDFS shows significant potential for separating low-abundance plasma proteins, extending detection limits.
• The '4RS' and '4S' criteria are crucial for assessing MDFS suitability for biomarker discovery.
• Optimizing sample processing, yield, and throughput is essential for effective MDFS application.

Conclusions:

• MDFS is a powerful tool for enhancing the sensitivity and scope of plasma biomarker discovery.
• Further research and optimization of MDFS are needed to fully realize its potential in clinical applications.
• The '4RS' and '4S' criteria provide a robust framework for evaluating and advancing MDFS technologies for biomarker research.